Randomized Phase 2 Trial of Axitinib and TRC105 Versus Axitinib Alone in Patients Renal Cell Carcinoma
Clinical trial NCT01806064 · TERMINATED
Trial details
- NCT number
- NCT01806064
- Sponsor
- Tracon Pharmaceuticals Inc.
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-03-08
- Primary completion
- 2018-12-21
- Enrollment
- 173
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.